The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Dr. Giribabu Nelli is a Senior Lecturer within the Department of Physiology at Universiti Malaya.
Hi primary research areas include, Reproductive Biology, Diabetes and their complications, and Natural Products Research.
Since 2011 she leads a research group in Gene Therapy and Cancer at IDIBAPS, Barcelona. Over the years she has contributed to the gene therapy field with more than 80 publications. She was among the team members that promote the constitution of the Spanish Society of Gene and Cell Therapy and served as Scientific Secretary from 2005 to 2011. She is editorial board member of several journals and Associate Editor of the Current Gene Therapy.
Alexandra Moreira obtained her D.Phil in Molecular Biology from Wolfson College at the University of Oxford in 1997. Her doctorate studies were conducted under Nick Proudfoot supervision at the Sir William Dunn School of Pathology, University of Oxford where she investigated the mRNA 3’ end formation mechanism of the human C2 complement. She was a postdoctoral fellow with Claudio Sunkel at the IBMC, and in 2003 formed the Group of Cell Activation and Gene Expression. She is currently a Professor in Molecular Biology and holds a Principal Investigator position at ICBAS, University of Porto. Together with her research activities, Alexandra Moreira is a member of the Scientific Board of the Molecular and Cell Biology PhD Program, University Porto. Since 2012 Alexandra Moreira is the Leader of the Group Gene Regulation at IBMC-i3S. The objective of her research group is to understand the molecular mechanisms involved in the integration between RNAPII transcription and alternative pre-mRNA processing, with a focus on polyadenylation, and on those events that are physiologically relevant in Eukaryotes.
Aaron Quinlan, Ph.D., is an Associate Professor in the Departments of Human Genetics and Biomedical Informatics at the University of Utah. He obtained his bachelor’s degree from the College of William and Mary and his Ph.D. from Boston College where he focused on population genetics, new methods for emerging DNA sequencing technologies, and the discovery and characterization of genetic variation. He performed a postdoctoral fellowship at the University of Virginia where he developed expertise in structural variation of mammalian genomes and somatic genome mutation. He started his laboratory at the University of Virginia in 2011 and began his faculty position at the University of Utah in early 2015. Broadly speaking, his research is focused on the development and application of new computational and statistical techniques for understanding the biology of the genome. His team tackles problems with practical importance to understanding genome variation, chromosome evolution and mining genetic variation related to human disease. Understanding the genome is a hard problem: we try to develop new approaches to gain insight into genome evolution in the context of disease.
Head of computational biology and the genetics and rare disease program at the Telethon Kids Institute. Interested in sequence analysis, large scale data integration and medical genomics. Past: RIKEN, Karolinska Institute, King's College London.
Mainly involved in the discovery of new bioactive compounds from Antarctic and Arctic bacteria. Also working on on Antarctic psychrophilic microorganisms with potential biotechnological applications, and the dissection of the virulence determinants of some human pathogens by the use of non-vertebrate host model, like Caenorhabtidis elegans.
I did my PhD at King's College London in the Lab of Prof J.M. Littleton working on adaptive mechanisms underlying drug dependence. I demonstrated adaptive changes in the number of DHP sensitive VOCC following chronic exposure to central depressant drugs and showed that these changes were associated with genetic vulnerability to drug dependence.
I undertook post-doc training at the Clinical Research Centre Harrow, UK before joining the laboratory of Prof Nigel Holder at The Randall Institute, KCL and moving with him to UCL in 1998. Whilst at KCL and UCL I used zebrafish as a genetic model system for analysis of mechanisms underlying development.
Since 2000, I have been a Lecturer in Molecular Genetics in the School of Biological Sciences QMUL. Our work combines the two areas of my expertise: Molecular mechanisms underlying drug dependence and zebrafish as a developmental genetic model system. We have developed behavioural assays of drug seeking, compulsive drug seeking and relapse in zebrafish and are establishing lines of fish in which to explore the genetics contributing to these behaviours.
Studies in Biology at University of Bern, Switzerland; PhD on regulation of alternative splicing at the Karolinska Intitute, Stockholm, Sweden and at Uppsala University, Sweden; Postdoc on post-transcriptional mRNA surveillance at Brandeis University, Boston, USA; research group leader (since 2000) and full professor (since 2010) at the University of Bern, working on mRNA surveillance, turnover and splicing. Director of the Swiss national research center (NCCR) on RNA and disease
Associate Director fo Computational Sciences, The Jackson Laboratory for Genomic Medicine, CT, USA. Previously worked at the Peter MacCallum Cancer Center in Melbourne Australia and at the Genome Institute of Singapore.
Stream Ecologist, wandering scholar, currently Prometeo Fellow of the Secretariat for Higher Education, Science, Technology, and Innovation of the Republic of Ecuador. Formerly Marie Curie International Incoming Fellow, University of Birmingham. Board of Directors, Freshwaters Illustrated. Newsletter editor and Hynes Award winner, Society for Freshwater Science.
2013- Senior Lecturer, University of Manchester, Manchester, UK
2006-13 Lecturer, University of Manchester, Manchester, UK
2001-06 Junior Group Leader Max-Planck Institute of Immunobiology in Freiburg, Germany
2000-01 Postdoctoral Fellow, Max-Planck Institute of Immunobiology in Freiburg, Germany
1996 PhD, University of Genova, Italy and Institute of Molecular Pathology, Vienna, Austria
1989 Degree in Biological Sciences, University of Genoa, Italy
The Director of the Integrated Plant Protection Center at Oregon State University and Professor in the Department of Environmental and Molecular Toxicology, State IPM Coordinator for Oregon and Associate Director of the Western IPM Center. Leads an international research and extension program in agriculture, leading to a sustainable intensification of production that contributes to food security.